Niagen Bioscience boosts share repurchase program

Niagen Bioscience has significantly increased its share repurchase program, authorizing an additional $20 million in buybacks. This move signals the company's confidence in its current valuation and its commitment to returning capital to shareholders. The expanded program suggests management believes the company's stock is undervalued, making it an attractive investment for buybacks. Such actions can often support the stock price and indicate a positive outlook on future financial performance and operational stability.